CA3283535A1 - Composés tricycliques pour le traitement du cancer - Google Patents

Composés tricycliques pour le traitement du cancer

Info

Publication number
CA3283535A1
CA3283535A1 CA3283535A CA3283535A CA3283535A1 CA 3283535 A1 CA3283535 A1 CA 3283535A1 CA 3283535 A CA3283535 A CA 3283535A CA 3283535 A CA3283535 A CA 3283535A CA 3283535 A1 CA3283535 A1 CA 3283535A1
Authority
CA
Canada
Prior art keywords
cancer
treatment
tricyclic compounds
tricyclic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3283535A
Other languages
English (en)
Inventor
Jianguo Chen
Lei Guo
Haixia Liu
Hong Shen
Junwei XI
Weixing ZHANG
Dan Zhao
Wei Zhu
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CA3283535A1 publication Critical patent/CA3283535A1/fr
Pending legal-status Critical Current

Links

CA3283535A 2023-02-14 2024-02-08 Composés tricycliques pour le traitement du cancer Pending CA3283535A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2023/075911 2023-02-14
CNPCT/CN2023/115515 2023-08-29
CNPCT/CN2024/074420 2024-01-29

Publications (1)

Publication Number Publication Date
CA3283535A1 true CA3283535A1 (fr) 2024-08-22

Family

ID=

Similar Documents

Publication Publication Date Title
AU2024220916A1 (en) Tricyclic compounds for the treatment of cancer
IL316706A (en) Macrocycle compounds for cancer treatment
EP3781564A4 (fr) Composés pour le traitement d'un cancer
CA3264256A1 (fr) Composés pour le traitement du cancer
EP4199961A4 (fr) Méthodes d'immunothérapie combinée pour le traitement d'un cancer
CA3262155A1 (fr) Composés pour le traitement du cancer
CA3283535A1 (fr) Composés tricycliques pour le traitement du cancer
AU2022231043A1 (en) Chaperonin-containing tcp-1 inhibitors for the treatment of cancer
AU2021372815A9 (en) Combination treatment of cancer
HK40130914A (zh) 用於治疗癌症的双环杂环化合物
CA3308038A1 (fr) Compositions pour traiter le cancer
HK40114414A (en) Dr5-targeting multabodies for the treatment of cancer
HK40094743A (en) Combinations for the treatment of cancer
CA3292752A1 (fr) Dérivés d'oxopipérazine pour le traitement du cancer
CA3270474A1 (fr) Anticorps anti-bssl pour traiter le cancer
CA3284076A1 (fr) Agents thérapeutiques dirigés contre l'os pour le traitement du cancer
HK40130970A (en) Combination therapy for the treatment of cancer
CA3271803A1 (fr) Polythérapie pour le traitement du cancer
HK40129364A (en) Combination therapy for the treatment of cancer
HK40114518A (en) Combination therapy for the treatment of cancer
GB202508597D0 (en) Compounds for the treatment of cancer
HK40097084A (en) Multispecific antibodies for the treatment of cancer
HK40119944A (en) Use of niraparib for the treatment of brain cancer
HK40112300A (en) Methods for the treatment of cancer
CA3263777A1 (fr) Dysosmobacter pour le traitement du cancer du sein